These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27698012)

  • 21. Structure and function of snake venom toxins interacting with human von Willebrand factor.
    Matsui T; Hamako J
    Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced high shear platelet adhesion to the vascular media: defective von Willebrand factor binding to the interstitial collagen.
    Komorowic E; McBane RD; Charlesworth J; Fass DN
    Thromb Haemost; 2002 Apr; 87(4):763-70. PubMed ID: 12013023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A biophysical view on von Willebrand factor activation.
    Löf A; Müller JP; Brehm MA
    J Cell Physiol; 2018 Feb; 233(2):799-810. PubMed ID: 28256724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
    Lood C; Gullstrand B; Truedsson L; Olin AI; Alm GV; Rönnblom L; Sturfelt G; Eloranta ML; Bengtsson AA
    Arthritis Rheum; 2009 Oct; 60(10):3081-90. PubMed ID: 19790049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
    Chen PC; Wang CR; Liu MF; Chen FF; Liang CC
    Asian Pac J Allergy Immunol; 2002 Dec; 20(4):223-7. PubMed ID: 12744622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A1 domain of von Willebrand factor.
    Shinagawa A; Kojima H; Berndt MC; Kaneko S; Suzukawa K; Hasegawa Y; Shigeta O; Nagasawa T
    Thromb Haemost; 2005 May; 93(5):889-96. PubMed ID: 15886805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes.
    Kishore U; Sontheimer RD; Sastry KN; Zappi EG; Hughes GR; Khamashta MA; Reid KB; Eggleton P
    Clin Exp Immunol; 1997 May; 108(2):181-90. PubMed ID: 9158084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are integrin alpha(2)beta(1), glycoprotein Ib and vWf levels correlated with their contributions to platelet adhesion on collagen under high-shear flow?
    Jung SM; Sonoda M; Tsuji K; Jimi A; Nomura S; Kanaji T; Moroi M
    Platelets; 2010; 21(2):101-11. PubMed ID: 20063990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of von Willebrand factor antigen release by immunoglobulin from thrombosis prone patients with systemic lupus erythematosus and the anti-phospholipid syndrome.
    Lindsey NJ; Dawson RA; Henderson FI; Greaves M; Hughes P
    Br J Rheumatol; 1993 Feb; 32(2):123-6. PubMed ID: 8428224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in Macrophages.
    Thanei S; Trendelenburg M
    J Immunol; 2016 Mar; 196(5):2063-74. PubMed ID: 26829984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C1q knock-out mice for the study of complement deficiency in autoimmune disease.
    Botto M
    Exp Clin Immunogenet; 1998; 15(4):231-4. PubMed ID: 10072632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
    Li X; Gabriel DA
    Biochemistry; 1997 Sep; 36(35):10760-7. PubMed ID: 9271507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C1q, autoimmunity and apoptosis.
    Botto M; Walport MJ
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights into von Willebrand disease and platelet function.
    Szántó T; Joutsi-Korhonen L; Deckmyn H; Lassila R
    Semin Thromb Hemost; 2012 Feb; 38(1):55-63. PubMed ID: 22314604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1q and systemic lupus erythematosus.
    Walport MJ; Davies KA; Botto M
    Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The association of von Willebrand factor and von Willebrand factor-cleaving protease in systemic lupus erythematosus].
    Lu GY; Guo XF; Wang ZY; Bai X; Su J; Ruan CG
    Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):42-4. PubMed ID: 16624087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13.
    Kragh T; Napoleone M; Fallah MA; Gritsch H; Schneider MF; Reininger AJ
    Thromb Res; 2014 Jun; 133(6):1079-87. PubMed ID: 24681085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
    Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
    Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombosis and von Willebrand Factor.
    Shahidi M
    Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.